Murray Robinson
16Patents
5h-index
28Co-inventors
66Inventor score
Filing activity: Jan 19, 1993 → Apr 25, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5489743A | Transgenic animal models for thrombocytopenia | Chemistry; Metallurgy | 72 | Expired |
| US5919656A | Genes encoding telomerase protein 1 | Chemistry; Metallurgy | 24 | Expired |
| US5973119A | Cyclin E genes and proteins | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5981707A | Genes encoding telomerase protein 1 | Chemistry; Metallurgy | 8 | Expired |
| US7390891B1 | Polynucleotides encoding a telomerase component TP2 | Chemistry; Metallurgy | 5 | Expired |
| US6174703A | Genes encoding telomerase protein 1 | Chemistry; Metallurgy | 3 | Expired |
| US9896730B2 | Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment | Chemistry; Metallurgy | 3 | Active |
| US7736861B1 | Tivozanib response prediction | Physics | 2 | Active |
| US8373017B2 | Reconstituted human breast tumor model | Chemistry; Metallurgy | 2 | Active |
| US6165753A | Cyclin E genes and proteins | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7622630B2 | Chimeric cancer models | Chemistry; Metallurgy | 0 | Expired |
| US9345788B2 | Reconstituted human breast tumor model | Chemistry; Metallurgy | 0 | Active |
| US7556796B2 | Directed complementation | Chemistry; Metallurgy | 0 | Active |
| US7455963B2 | Antibodies to cyclin E2 protein | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6943238B2 | Antibodies to cyclin E2 protein | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7615353B1 | Tivozanib response prediction | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.